Correlation Engine 2.0
Clear Search sequence regions

  • endolysins (5)
  • enzymes (1)
  • half life (1)
  • humans (1)
  • hydrolases (1)
  • past (1)
  • patients (1)
  • peptidoglycan (1)
  • research (1)
  • Sizes of these terms reflect their relevance to your search.

    The rapid emergence of antibiotic-resistant bacteria and the lack of novel antibacterial agents pose a serious threat for patients and healthcare systems. Bacteriophage-encoded peptidoglycan hydrolases (endolysins) represent a promising new class of antimicrobials. Over the past two decades, research on these enzymes has evolved from basic in vitro characterization to sophisticated protein engineering approaches, including advanced preclinical and clinical testing. In recent years, increasingly specific animal models have shown efficacy of endolysins against bacterial infections of various different organs and tissues of the body. Despite these advances, some challenges with regard to systemic application of endolysins remain to be addressed. These include immunogenicity, circulation half-life, and cell and tissue-specific targeting and penetration properties. Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.


    Mathias Schmelcher, Martin J Loessner. Bacteriophage endolysins - extending their application to tissues and the bloodstream. Current opinion in biotechnology. 2021 Apr;68:51-59

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 33126104

    View Full Text